Stay updated on PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page
- Check7 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1. The study record page still displays a 403 Forbidden error instead of trial details.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page now shows a 403 Forbidden error, preventing access to the study record. This indicates a permissions/server issue rather than a change to the page content.SummaryDifference0.5%

- Check21 days agoChange DetectedThe Study record page now displays a 403 Forbidden error with a simple Home link, replacing the previously accessible content.SummaryDifference19%

- Check28 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the site's software. This change does not modify the study details or visible content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page displays a new revision label: v3.6.6 replacing v3.6.5, indicating a small metadata update to the page.SummaryDifference0.0%

- Check49 days agoChange DetectedA line '2023 ( U.S. NIH Grant/Contract )' was added under Study ID Numbers to indicate NIH funding support for the trial. This funding attribution is part of the metadata and does not change how the study is conducted or presented to participants.SummaryDifference0.0%

Stay in the know with updates to PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.